Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
RXO Quote, Financials, Valuation and Earnings
Last price:
$16.63
Seasonality move
:
-6.13%
Day range:
$15.77 - $16.50
52-week range:
$12.19 - $32.82
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.47x
P/B ratio:
1.67x
Volume:
1.2M
Avg. volume:
1.8M
1-year change:
-45.83%
Market cap:
$2.6B
Revenue:
$4.6B
EPS (TTM):
-$2.17
Analysts' Opinion
-
Consensus RatingRXO has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 14 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.57, RXO has an estimated upside of 2.51% from its current price of $16.16.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 31.93% downside risk from its current price of $16.16.
Fair Value
-
According to the consensus of 19 analysts, RXO has 2.51% upside to fair value with a price target of $16.57 per share.
RXO vs. S&P 500
-
Over the past 5 trading days, RXO has underperformed the S&P 500 by -6.22% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
RXO does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
RXO has grown year-over-year revenues for 3 quarters straight. In the most recent quarter RXO reported revenues of $1.4B.
Earnings Growth
-
RXO earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter RXO reported earnings per share of -$0.18.
Enterprise value:
3B
EV / Invested capital:
--
Price / LTM sales:
0.47x
EV / EBIT:
1,080.76x
EV / Revenue:
0.60x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-43.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
63.57x
Gross Profit (TTM):
$751M
Return On Assets:
-11.15%
Net Income Margin (TTM):
-6.04%
Return On Equity:
-25.45%
Return On Invested Capital:
-19.36%
Operating Margin:
-0.7%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $4.5B | $3.8B | $5.1B | $913M | $1.4B | |
| Gross Profit | $817M | $631M | $751M | $145M | $200M | |
| Operating Income | $185M | $48M | $20M | -- | -$10M | |
| EBITDA | $137M | $83M | -$188M | $3M | $2M | |
| Diluted EPS | $0.47 | -$0.09 | -$2.17 | -$0.13 | -$0.18 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $1B | $770M | $1.3B | |
| Total Assets | -- | -- | $2B | $1.8B | $3.3B | |
| Current Liabilities | -- | -- | $820M | $674M | $964M | |
| Total Liabilities | -- | -- | $1.4B | $1.2B | $1.7B | |
| Total Equity | -- | -- | $585M | $582M | $1.6B | |
| Total Debt | -- | -- | $455M | $367M | $404M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $249M | $54M | -$21M | $7M | -$2M | |
| Cash From Investing | -$56M | -$65M | -$1.1B | -$11M | -$25M | |
| Cash From Financing | -$117M | -$103M | $1.1B | $6M | $7M | |
| Free Cash Flow | $192M | -$9M | -$70M | -$4M | -$17M | |
RXO
Sector
Market Cap
$2.6B
$611.3M
Price % of 52-Week High
49.24%
81.21%
Dividend Yield
0%
0%
Shareholder Yield
--
2.28%
1-Year Price Total Return
-45.83%
-1.12%
Beta (5-Year)
--
0.761
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$16.82
200-day SMA
Sell
Level
$21.53
Bollinger Bands (100)
Sell
Level
14.31 - 18.61
Chaikin Money Flow
Buy
Level
851.3K
20-day SMA
Sell
Level
$16.28
Relative Strength Index (RSI14)
Sell
Level
48.65
ADX Line
Sell
Level
17.36
Williams %R
Neutral
Level
-74.5174
50-day SMA
Buy
Level
$15.92
MACD (12, 26)
Buy
Level
4.54
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
1.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3378)
Sell
CA Score
(Annual)
Level (-0.6162)
Sell
Beneish M-Score
(Annual)
Level (-2.0832)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (0.2313)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Stock Forecast FAQ
In the current month, RXO has received 3 Buy ratings 14 Hold ratings, and 2 Sell ratings. The RXO average analyst price target in the past 3 months is $16.57.
-
Where Will RXO Stock Be In 1 Year?
According to analysts, the consensus estimate is that RXO share price will rise to $16.57 per share over the next 12 months.
-
What Do Analysts Say About RXO?
Analysts are divided on their view about RXO share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RXO is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is RXO's Price Target?
The price target for RXO over the next 1-year time period is forecast to be $16.57 according to 19 Wall Street analysts, 3 of them rate the stock a Buy, 2 rate the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is RXO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for RXO is a Hold. 14 of 19 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RXO?
You can purchase shares of RXO via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RXO shares.
-
What Is The RXO Share Price Today?
RXO was last trading at $16.63 per share. This represents the most recent stock quote for RXO. Yesterday, RXO closed at $16.16 per share.
-
How To Buy RXO Stock Online?
In order to purchase RXO stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
